Acura Pharmaceuticals Basic Shares Outstanding 2010-2021 | ACUR

Acura Pharmaceuticals basic shares outstanding from 2010 to 2021. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
Acura Pharmaceuticals Annual Basic Shares Outstanding
(Millions of US $)
2021 $57
2020 $32
2019 $27
2018 $21
2017 $16
2016 $12
2015 $11
2014 $10
2013 $10
2012 $10
2011 $10
2010 $9
2009 $9
Acura Pharmaceuticals Quarterly Basic Shares Outstanding
(Millions of US $)
2021-12-31 $57
2021-09-30 $76
2021-06-30 $43
2021-03-31 $32
2020-12-31 $32
2020-09-30 $32
2020-06-30 $32
2020-03-31 $32
2019-12-31 $27
2019-09-30 $32
2019-06-30 $22
2019-03-31 $21
2018-12-31 $21
2018-09-30 $21
2018-06-30 $21
2018-03-31 $21
2017-12-31 $16
2017-09-30 $17
2017-06-30 $12
2017-03-31 $12
2016-12-31 $12
2016-09-30 $12
2016-06-30 $12
2016-03-31 $12
2015-12-31 $11
2015-09-30 $12
2015-06-30 $10
2015-03-31 $10
2014-12-31 $10
2014-09-30 $10
2014-06-30 $10
2014-03-31 $10
2013-12-31 $10
2013-09-30 $9
2013-06-30 $9
2013-03-31 $9
2012-12-31 $10
2012-09-30 $10
2012-06-30 $10
2012-03-31 $10
2011-12-31 $10
2011-09-30 $10
2011-06-30 $9
2011-03-31 $9
2010-12-31 $9
2010-09-30 $9
2010-06-30 $9
2010-03-31 $9
2009-12-31 $9
2009-09-30 $9
2009-06-30 $9
2009-03-31 $9
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.207B 6.94
Dr Reddy's Laboratories (RDY) India $12.054B 21.88
BridgeBio Pharma (BBIO) United States $6.426B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.872B 15.19
Bausch Health Cos (BHC) Canada $1.692B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.181B 7.87
Taysha Gene Therapies (TSHA) United States $0.580B 0.00
Personalis (PSNL) United States $0.437B 0.00
Assembly Biosciences (ASMB) United States $0.103B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00